Lindis Blood Care Announces Publication of Clinical Pilot Study Results
Finance News Lindis Blood Care Announces Publication of Clinical Pilot Study Results Successfully Highlighting the Potential of CATUVAB® in the Removal of Tumor Cells from [...]
Tumorzellfreies Eigenblut bei Krebsoperationen
Finance News Tumorzellfreies Eigenblut bei Krebsoperationen Hennigsdorf (Berlin), Germany: September 3, 2021. Aus dem brandenburgischen Hennigsdorf kommt eine Innovation, die als neuer „Goldstandard“ die Eigenbluttransfusion [...]
Lindis’ Catuvab is designed to remove tumor cells from surgical blood
Finance News Lindis’ Catuvab is designed to remove tumor cells from surgical blood Hennigsdorf, Berlin, Germany - April 2, 2021. Lindis Blood Care GmbH launched [...]
Lindis Initiates Clinical EU Certification Study REMOVE with CATUVAB®
Finance News Lindis Blood Care Initiates Multicenter Clinical EU Certification Study REMOVE with CATUVAB® to Eliminate Tumor Cells from Surgical Blood Hennigsdorf, Berlin, Germany - [...]
Financing News
Finance News Over 5 million euros for Lindis Blood Care: development of a new product for the removal of tumor cells from surgical blood Hennigsdorf [...]